Developmental and reproductive safety of Advax-CpG55.2™ adjuvanted COVID-19 and influenza vaccines in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Developmental and reproductive safety of Advax-CpG55.2™ adjuvanted COVID-19 and influenza vaccines in mice

Published:2023-09 Issue:41 Volume:41 Page:6093-6104
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Sakala Isaac G.,Honda-Okubo Yoshikazu^ORCID,Petrovsky Nikolai^ORCID

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference54 articles.

1. World Health Organization. Weekly operational update on COVID-19-20 September 2021; 2021. p. 1–16.

2. COVID-19 vaccines;Ndwandwe;Curr Opin Immunol,2021

3. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection;Li;Vaccine,2021

4. Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety;Petrovsky;Vaccine,2015

5. Artificial intelligence in vaccine and drug design. Vaccine design;Thomas,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronavirus spike protein-based vaccines. Vaccine delivery systems;Medicine in Drug Discovery;2024-09

2. Advax-SM™-Adjuvanted COBRA (H1/H3) Hemagglutinin Influenza Vaccines;Vaccines;2024-04-24

3. Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults: An immuno-bridging clinical trial;International Immunopharmacology;2024-01

4. Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants;Vaccine;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3